Bristol-Myers Squibb has appointed Dr. Thomas J. Lynch, Jr., 56, executive vice president and chief scientific officer, effective March 16, 2017.

He succeeds Dr. Francis Cuss, 62, who will retire from the company.

In connection with the appointment, Dr. Lynch will step down from the Board of Directors of Bristol-Myers Squibb, effective March 15.

commentary by Endpoints News